Page last updated: 2024-09-03

reboxetine and Stroke

reboxetine has been researched along with Stroke in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiao, Y; Liang, Y; Lin, J; Qu, H; Sun, Y; Xu, J; Zhao, C1
Diekhoff, S; Eickhoff, SB; Fink, GR; Grefkes, C; Rehme, AK; Wang, LE1
Alvano, A; Chiechio, S; Malaguarnera, M; Nicoletti, G; Raffaele, R; Rampello, L; Vecchio, I1
Andersen, G; Møller, M1
Liepert, J; Weiller, C; Zittel, S1

Trials

2 trial(s) available for reboxetine and Stroke

ArticleYear
Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.
    Psychopharmacology, 2004, Volume: 173, Issue:1-2

    Topics: Adrenergic Uptake Inhibitors; Aged; Analysis of Variance; Case-Control Studies; Citalopram; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Morpholines; Predictive Value of Tests; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stroke; Treatment Outcome

2004
Reboxetine improves motor function in chronic stroke. A pilot study.
    Journal of neurology, 2007, Volume: 254, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Analysis of Variance; Chronic Disease; Double-Blind Method; Female; Functional Laterality; Hand Strength; Humans; Male; Middle Aged; Morpholines; Physical Therapy Specialty; Pilot Projects; Psychomotor Performance; Reboxetine; Severity of Illness Index; Stroke; Stroke Rehabilitation; Transcranial Magnetic Stimulation

2007

Other Studies

3 other study(ies) available for reboxetine and Stroke

ArticleYear
Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
    BMJ open, 2017, Aug-03, Volume: 7, Issue:8

    Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder; Doxepin; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Paroxetine; Patient Acceptance of Health Care; Reboxetine; Selective Serotonin Reuptake Inhibitors; Stroke; Treatment Outcome

2017
Noradrenergic enhancement improves motor network connectivity in stroke patients.
    Annals of neurology, 2011, Volume: 69, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Cross-Over Studies; Double-Blind Method; Hand Strength; Humans; In Vitro Techniques; Magnetic Resonance Imaging; Male; Middle Aged; Morpholines; Motor Cortex; Paresis; Psychomotor Performance; Reboxetine; Recovery of Function; Stroke

2011
Inhibition of selective noradrenergic reuptake as treatment of pathological laughter.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adult; Affective Symptoms; Humans; Laughter; Male; Middle Aged; Morpholines; Multiple Sclerosis; Reboxetine; Stroke

2007